Manufacturers Life Insurance Company, The Avadel Pharmaceuticals PLC Transaction History

Manufacturers Life Insurance Company, The

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2018 Nov 14, 2018	SELL	$4.08 - $7.14 $840 - $1,470	-206 Closed	0 $0
Q2 2018 Aug 14, 2018	BUY	$5.89 - $7.78 $111 - $147	19 Added 10.16%	206 $1,000
Q1 2018 May 15, 2018	BUY	$6.76 - $11.7 $162 - $280	24 Added 14.72%	187 $1,000
Q4 2017 Feb 08, 2018	BUY	$8.03 - $11.25 $184 - $258	23 Added 16.43%	163 $1,000
Q3 2017 Nov 14, 2017	BUY	$8.35 - $10.5 $1,169 - $1,470	140	140 $1,000

1.07M

Ticker AVDL
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 60,581,300
Market Cap $661M
Description
Avadel Pharmaceuticals plc operates as a biopharmaceutical company in the United States. Its lead product candidate is FT218, a formulation of sodium oxybate, which is in a Phase 3 clinical trial for the treatment of excessive daytime sleepiness and cataplexy in adults with narcolepsy. The company was formerly known as Flamel Technologies SA and...

Get notified when there are updates to the investment portfolio of Manufacturers Life Insurance Company, The, based on Form 13F filings with the SEC.

Stay updated on Manufacturers Life Insurance Company, The with notifications on news.